Sumit Agrawal

Sumit Agrawal

Active Director Director DIN 07188796
DIN 07188796 First appointment May 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2015
Shareholding value •••• Premium profile

About Sumit Agrawal

Data last updated:

Sumit Agrawal is a Director at Vision Parenteral Private Limited (since 2015). The company operates in Pharma. Vision Parenteral Private Limited reported revenue of ₹64.47 Cr (FY 2025).

DIN 07188796
Primary Designation Director
Industry Pharma
First Appointment 29 May 2015
Oldest Company Age 15 yrs
Largest company Vision Parenteral Private Limited · ₹64.47 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vision Parenteral Private Limited U24233UP2011PTC045130
Director29 May 20152011₹64.47 Cr (FY 2025)Active

Board colleagues of Sumit Agrawal

Directorship timeline

Open interactive timeline →
Vision Parenteral Private Limited
Premium access

Shareholding and investment profile for Sumit Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumit Agrawal

Sumit Agrawal currently holds 1 directorship: Vision Parenteral Private Limited (Director, since 29 May 2015, revenue ₹64.47 Cr (FY 2025)).

Sumit Agrawal was first appointed on 29 May 2015 as Director at Vision Parenteral Private Limited.

The current boards of Sumit Agrawal's companies include Sandeep Agrawal (Vision Parenteral Private Limited), Subodh Agrawal (Vision Parenteral Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available